Mealey's (September 12, 2019, 12:34 PM EDT) -- WILMINGTON, Del. — In a Sept. 10 decision, a federal judge in Delaware rejected a request by GlaxoSmithKline LLC and Glaxo Group Limited (Glaxo, collectively) for a new trial on allegations that it directly and indirectly infringed a patent relating to pharmaceutical compositions for inhalation (Vectura Limited v. GlaxoSmithKline LLC, et al., No. 16-638, D. Del., 2019 U.S. Dist. LEXIS 153621)....